Breaking News, World News and Taiwan News.

H7N9 flu vaccine set for mass production in June

TAIPEI -- A Taiwan-made vaccine for the H7N9 strain of avian flu is expected to begin mass production in June this year after completing human trials, Taichung-based Adimmune Corp. said Thursday.

Adimmune, the only human vaccine producer in Taiwan, said it has completed animal trials and will begin a second phase of human trials for its H7N9 vaccine in March.

One of the world's first GMP vaccine manufacturers to engage in research and development of a vaccine for H7N9, the company said it will be able to produce 3 million doses of the vaccine per month once mass-production has begun.

Even if the Taiwan government does not purchase the vaccines, Adimmune said it will continue with development so that it will be ready to start mass-producing them at any time should there be a need.

Write a Comment
CAPTCHA Code Image
Type in image code
Change the code
 Receive China Post promos
 Respond to this email
Subscribe  |   Advertise  |   RSS Feed  |   About Us  |   Career  |   Contact Us
Sitemap  |   Top Stories  |   Taiwan  |   China  |   Business  |   Asia  |   World  |   Sports  |   Life  |   Arts & Leisure  |   Health  |   Editorial  |   Commentary
Travel  |   Movies  |   TV Listings  |   Classifieds  |   Bookstore  |   Getting Around  |   Weather  |   Guide Post  |   Student Post  |   Terms of Use  |   Sitemap
  chinapost search